I f prostate cancer has spread to other areas of your body, your doctor may recommend androgen deprivation therapy (ADT), which halts the production of androgen hormones, especially testosterone.

Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...

Androgen deprivation is the mainstay of therapy of advanced prostate cancer treatment, but the cure rate is low and patients eventually become castrate resistant. Castration-resistant prostate ...

Expert Rev Endocrinol Metab. 2009;5(5):417-422. After an initial response to androgen deprivation therapy, prostate cancer relapses and growth of prostate cancer is independent of androgens ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

In North American studies, heart failure risk appeared to be lower among patients receiving ADT than it was for the overall analysis, whereas the risk with ADT across Asian studies was higher.

In a live event, Vinay Minocha, MD, discusses the addition of darolutamide to androgen deprivation therapy for in patients ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on the rise. In Thailand, it is the 4th most common cancer among men (1), ...

Prostate cancer is the most common ... valacyclovir, radiation therapy and potentially short-term androgen deprivation therapy (ADT). Meanwhile, the placebo group received placebo, valacyclovir ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with ...